ALRN-6924 vs Mambalgin-1

Head-to-head comparison of ALRN-6924 (ALRN-6924 dual MDM2/MDMX stapled p53 mimetic peptide) and Mambalgin-1 (Mambalgin-1 from Dendroaspis polylepis venom) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyALRN-6924Mambalgin-1
CategoryExperimentalExperimental
Full NameALRN-6924 dual MDM2/MDMX stapled p53 mimetic peptideMambalgin-1 from Dendroaspis polylepis venom
Molecular WeightN/A6,300 Da
Half-LifeHours to days depending on formulationMinutes to hours
Amino AcidsN/A57
Typical DoseVaries by clinical protocol0.1-1 nmol intrathecal|10-100 nM in vitro|single-dose rodent studies
RouteIntravenous/SubcutaneousIntrathecal
Purity≥98%≥98%
Studies Count4055
Research StatusClinicalPre-clinical

ALRN-6924 Benefits

  • p53 reactivation
  • dual MDM2/MDMX inhibition
  • protease resistance
  • tumor cell apoptosis

Mambalgin-1 Benefits

  • ASIC channel inhibition
  • non-opioid analgesia research
  • sensory-neuron physiology
  • lead optimization for pain therapeutics

ALRN-6924 Dosing

Clinical trial protocol dosing|Intermittent administration|Research-only escalation

Mambalgin-1 Dosing

Intrathecal pain-behavior studies|ASIC1a/ASIC1b electrophysiology|Acute dosing in rodents

ALRN-6924 Side Effects

  • nausea
  • fatigue
  • myelosuppression

Mambalgin-1 Side Effects

  • Hypoactivity at high dose
  • off-target ASIC blockade
  • local irritation

Research Overview

ALRN-6924

ALRN-6924 is one of the best-known stapled peptide therapeutics and has advanced into human oncology studies. Literature shows that hydrocarbon stapling can improve target affinity, serum stability, and cellular activity for this p53-mimetic scaffold.

Mambalgin-1

Pre-clinical work shows mambalgin-1 can reduce pain behaviors by modulating proton-gated ion channels in peripheral and central pathways. It has become an important template for developing ASIC-targeted analgesics.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

ALRN-6924 stacks with:

venetoclaxcisplatindoxorubicin

Mambalgin-1 stacks with:

gabapentinbaclofenlidocaine
stapled-peptidep53mdm2mdmxoncologysnake-venomthree-finger-toxinasic-blockerpain-research